SCHEMBL31403127

SCHEMBL31403127

CC(C)(C)OC(=O)N1CCC(Oc2cc(C(=O)O)cc(Cl)n2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 11/20 0.50
▸ TOP2A P11388 1/20 0.48
▸ CACNB4 O00305 2/20 0.47
▸ CACNA1A O00555 2/20 0.47
▸ CACNA1G O43497 2/20 0.47
▸ CACNG3 O60359 2/20 0.47
▸ CACNA1F O60840 2/20 0.47
▸ CACNA1H O95180 2/20 0.47
▸ CACNB3 P54284 2/20 0.47
▸ CACNA2D1 P54289 2/20 0.47
▸ CACNG7 P62955 2/20 0.47
▸ CACNA1B Q00975 2/20 0.47
▸ CACNA1D Q01668 2/20 0.47
▸ CACNB1 Q02641 2/20 0.47
▸ CACNG1 Q06432 2/20 0.47
▸ CACNB2 Q08289 2/20 0.47
▸ CACNA1S Q13698 2/20 0.47
▸ CACNA1C Q13936 2/20 0.47
▸ CACNA1E Q15878 2/20 0.47
▸ CACNA2D4 Q7Z3S7 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15390694 0.85 GPR119 (0.48) GPR119PDE4APDE4BPDE4CPDE4D
SCHEMBL12094684 0.83 CHRM2 (0.45) GPR119
SCHEMBL6121103 0.82 GPR119 (0.50) GPR119CACNB4CACNA1ACACNA1GCACNG3
SCHEMBL9893955 0.82 GPR119 (0.50) GPR119CACNB4CACNA1ACACNA1GCACNG3
SCHEMBL21144113 0.81 GPR119 (0.54) GPR119CACNB4CACNA1ACACNA1GCACNG3
SCHEMBL17572116 0.81 GPR119 (0.53) GPR119TOP2ACACNB4CACNA1ACACNA1G
SCHEMBL3505435 0.81 GPR119 (0.53) GPR119CACNB4CACNA1ACACNA1GCACNG3
SCHEMBL1532690 0.81 GPR119 (0.55) GPR119CACNB4CACNA1ACACNA1GCACNG3
SCHEMBL27477692 0.80 GPR119 (0.52) GPR119CACNB4CACNA1ACACNA1GCACNG3
SCHEMBL1066568 0.79 GPR119 (0.57) GPR119CACNB4CACNA1ACACNA1GCACNG3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025021182-A1 CYP11A1 INHIBITORS ACERAND THERAPEUTICS (HONG KONG) LIMITED (CN) 2025-01-30 — — WO disclosed
Send feedback